Angelini C, Angelini C (2018) Congenital Myasthenic Syndrome. Genetic Neuromuscular Disorders: A Case-Based Approach,: pp. 229–231

Spalek P (1991) Congenital myasthenic syndrome. Ceskoslovenska neurologie a neurochirurgie. 54(4):198–200

Banerjee A et al (2022) Congenital myasthenic syndrome: a tale of two siblings. Int J Neurosci,: p. 1–3

Lorenzoni PJ et al (2012) Congenital myasthenic syndrome: a brief review. Pediatr Neurol 46(3):141–148

Article  PubMed  Google Scholar 

Saito M et al (2022) Successful treatment of congenital myasthenic syndrome caused by a novel compound heterozygous variant in RAPSN. Brain Develop 44(1):50–55

Article  CAS  Google Scholar 

Parvizi Omran S et al (2019) No hot spot mutations CHRNE c.1327 delG, CHAT c.914T > C, and RAPSN c.264C > A in Iranian patients with congenital myasthenic syndrome. Iran J Child Neurol 13(2):135–143

PubMed  PubMed Central  Google Scholar 

de Estephan P (2018) Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in Brazil. Neuromuscul Disord 28(11):961–964

Article  PubMed  Google Scholar 

Kramer J et al (2023) Dystrophic Myopathy of the diaphragm with recurrent severe respiratory failure is congenital myasthenic syndrome 11. J Neuromuscul Dis, (Preprint): p. 1–7

Ohno K et al (2023) Clinical and pathologic features of congenital myasthenic syndromes caused by 35 Genes—A Comprehensive Review. Int J Mol Sci 24(4):3730

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaaib JN, Nassief AF, Al-Assi A (2011) Simple salting-out method for genomic DNA extraction from whole blood. Tikrit J Pure Sci 16(2):1813–1662

Google Scholar 

Ghasemi A et al (2023) Description of phenotypic heterogeneity in a GJC2-Related family and literature review. Mol Syndromol,: p. 1–11

Ohno K et al (2002) Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. Am J Hum Genet 70(4):875–885

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alseth EH et al (2011) Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients. Muscle Nerve 43(4):574–577

Article  CAS  PubMed  Google Scholar 

Natera-de Benito D et al (2016) Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations. Neuromuscul Disord 26(2):153–159

Article  CAS  PubMed  Google Scholar 

Müller JS et al (2003) Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients. Neurology 60(11):1805–1810

Article  PubMed  Google Scholar 

Estephan EdP et al (2018) Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in Brazil. Neuromuscul Disord 28(11):961–964

Article  PubMed  Google Scholar 

Ohno K et al (2003) E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome. Hum Mol Genet 12(7):739–748

Article  CAS  PubMed  Google Scholar 

Leshinsky-Silver E et al (2012) A novel mutation in the TPR6 domain of the RAPSN gene associated with congenital myasthenic syndrome. J Neurol Sci 316(1):112–115

Article  CAS  PubMed  Google Scholar 

Das AS, Agamanolis DP, Cohen BH (2014) Use of next-generation sequencing as a diagnostic tool for congenital myasthenic syndrome. Pediatr Neurol 51(5):717–720

Article  PubMed  Google Scholar 

Hesami O et al (2024) COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum. Orphanet J Rare Dis 19(1):113

Article  PubMed  PubMed Central  Google Scholar 

Ziaadini B et al (2024) DOK7 congenital myasthenic syndrome: case series and review of literature. BMC Neurol 24(1):211

Article  CAS  PubMed  PubMed Central  Google Scholar 

Milone M et al (2009) Myasthenic syndrome due to defects in rapsyn: clinical and molecular findings in 39 patients. Neurology 73(3):228–235

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burke G et al (2003) Rapsyn mutations in hereditary myasthenia: distinct early-and late-onset phenotypes. Neurology 61(6):826–828

Article  CAS  PubMed  Google Scholar 

Ioos C et al (2004) Congenital myasthenic syndrome due to rapsyn deficiency: three cases with arthrogryposis and bulbar symptoms. Neuropediatrics 35(04):246–249

Article  CAS  PubMed  Google Scholar 

Banwell BL et al (2004) Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3, 4-diaminopyridine. Neuromuscul Disord 14(3):202–207

Article  PubMed  Google Scholar 

Espinoza IO et al (2019) Congenital myasthenic syndrome due to rapsyn deficiency: a case report with a new mutation and compound heterozygosity. Medwave 19(5):e7645

Article  PubMed  PubMed Central  Google Scholar 

McMacken G et al (2018) Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients. J Neurol 265:194–203

Article  CAS  PubMed  Google Scholar 

Palace J (2012) DOK7 congenital myasthenic syndrome. Ann N Y Acad Sci 1275(1):49–53

Article  CAS  PubMed  Google Scholar 

Engel AG et al (2015) Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol 14(4):420–434

Article  PubMed  PubMed Central  Google Scholar 

Visser AC et al (2017) Rapsyn congenital myasthenic syndrome worsened by fluoxetine. Muscle Nerve 55(1):131–135

Article  CAS  PubMed  Google Scholar